期刊
JOURNAL OF HUMAN GENETICS
卷 56, 期 1, 页码 34-40出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/jhg.2010.132
关键词
-
资金
- Ministry of Education, Culture, Sports, Science and Technology, Japan
- Research Committee on Moyamoya Disease of the Ministry of Health, Labor and Welfare, Japan
- Grants-in-Aid for Scientific Research [23390268] Funding Source: KAKEN
Moyamoya disease (MMD) shows progressive cerebral angiopathy characterized by bilateral internal carotid artery stenosis and abnormal collateral vessels. Although similar to 15% of MMD cases are familial, the MMD gene(s) remain unknown. A genome-wide association study of 785 720 single-nucleotide polymorphisms (SNPs) was performed, comparing 72 Japanese MMD patients with 45 Japanese controls and resulting in a strong association of chromosome 17q25-ter with MMD risk. This result was further confirmed by a locus-specific association study using 335 SNPs in the 17q25-ter region. A single haplotype consisting of seven SNPs at the RNF213 locus was tightly associated with MMD (P = 5.3 x 10(-10)). RNF213 encodes a really interesting new gene finger protein with an AAA ATPase domain and is abundantly expressed in spleen and leukocytes. An RNA in situ hybridization analysis of mouse tissues indicated that mature lymphocytes express higher levels of Rnf213 mRNA than their immature counterparts. Mutational analysis of RNF213 revealed a founder mutation, p.R4859K, in 95% of MMD families, 73% of non-familial MMD cases and 1.4% of controls; this mutation greatly increases the risk of MMD (P = 1.2 x 10(-43), odds ratio-190.8, 95% confidence interval-71.7-507.9). Three additional missense mutations were identified in the p.R4859K-negative patients. These results indicate that RNF213 is the first identified susceptibility gene for MMD. Journal of Human Genetics (2011) 56, 34-40; doi:10.1038/jhg.2010.132; published online 4 November 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据